A to Z Index Directions and Maps My Account People Finder Print This Page Search AU CVM Site Map Student & Faculty Resources AU College of Veterinary Medicine Home Page
Auburn University Home Page AU College of Veterinary Medicine Home Page
About The College
Academic Affairs
CE and Outreach
Departments
Programs at the College
Graduate Studies
Research at the College Admit An Animal Giving To The College News At The College Admissions
 
You Are Here: College of Veterinary Medicine > Departments > Anat / Phys / Pharm > Diagnostic Services > Clinical Pharmacology Lab > Therapeutic Drug Monitoring > Case 5

Case 5
Theophylline-enrofloxacin drug interaction


Signalment:  Six year old male neutered Collie

Chief Complaint:  Allergic rhinitis of 2 months duration. Radiographic evidence of lung-lobe consolidation and clinical signs compatible with pneumonia developed one week prior to presentation.

Pertinent History:  Theophylline therapy begun 3 days prior to presentation. Patient began exhibiting signs of hyperactivity and restlessness 24 hours prior to presentation.

Other Drugs:  Enrofloxacin 2.5 mg/kg every 12 hours orally (begun at same time as theophylline); prednisolone 1 mg/kg every 48 hours.

Drug of Interest:  Theophylline

Concern: Toxicity

Dosing Regimen:  21 mg/kg orally every 12 hours (slow release product)

Duration of Current Regimen:  3 days

Patient Response:  Restless, pacing, irritable

Drug Concentration:

47 mg/ml      Time: 12 hours
31 mg/ml      Time: 24 hours

Drug Elimination Half-Life:  19 hours

Volume of Distribution:  NA

Predicted Peak:  approx. 65 mg/ml

Predicted Trough:  NA

Recommendation:  Decrease the dose by half or decrease the dose by 25% and prolong the dosing interval by 12 hours to 24 hours. Retest at new steady-state (in three days) and upon discontinuation of enrofloxacin.

Follow-Up:  Following monitoring, the dosing interval was prolonged to 24 hours and dose was decreased by 50% from 20 mg/kg to 10 mg/kg. Recheck revealed a peak and trough concentration of 12.3 mg/ml and 10.3 mg/ml at 2 and 22 hours respectively. Near sub therapeutic concentrations indicated that either the dose must be increased or the interval decreased to 12 hours.

Comments:  The fluorinated quinolones can increase concentrations of theophylline when the two drugs are given simultaneously. The mechanism is presumed to be due to impaired drug metabolism by enrofloxacin with subsequent decreased theophylline clearance. This drug interaction is well established for ciprofloxacin in people and has been documented for enrofloxacin as well. The drug elimination half-life of theophylline in this patient while on enrofloxacin was 19 hours, which is twice that expected in dogs.

[back to top]

© Auburn University, College of Veterinary Medicine
:My Account:
Login
Webmaster
Disclaimer